Ethnic differences in the association of factor V Leiden mutation and the C677T methylenetetrahydrofolate reductase gene polymorphism with preeclampsia

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 112, Issue 2, 2004, Pages 162-169

  Prasmusinto, Damar ^a,c   Skrablin, Snezana ^b   Fimmers, Rolf ^a   Van Der Ven, Katrin ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c UNIVERSITY OF INDONESIA   (Indonesia)

Author keywords

Factor V Leiden mutation; German Croatian; Indonesian; MTHFR C677T; Preeclampsia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CROATIA; ETHNIC DIFFERENCE; ETHNIC GROUP; ETHNOLOGY; FEMALE; FETUS (ANATOMY); GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GERMANY; HUMAN; INDONESIA; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; NEWBORN; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR;

EID: 1642504829     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(03)00314-2     Document Type: Article

References (39)

1. Saftlas A.F., Olson D.R., Franks A.L., Atrash H., Pokras R. Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. Am. J. Obstet. Gynecol. 163:1990;460-465.
2. Kenny L., Baker P.N. Maternal pathophysiology in pre-eclampsia. Baillieres Best Pract. Res. Clin. Obstet. Gynaecol. 13(1):1999;59-75.
3. Rath W., Faridi A., Dudenhausen J.W. HELLP syndrome. J. Perinat. Med. 28(4):2000;249-260.
4. Sibai B.M. Medical disorders in pregnancy, including hypertensive diseases. Curr. Opin. Obstet. Gynecol. 2(1):1990;13-22.
5. Roberts J.M., Taylor R.N., Musci T.J., Rodgers G.M., Hubel C.A., McLaughin M.K. Preeclampsia: an endothelial cell disorder. Am. J. Obstet. Gynecol. 161:1989;1200-1204.
6. Roberts J.M., Cooper D.W. Pathogenesis and genetics of pre-eclampsia. Lancet. 357(9249):2001;53-56.
7. Lenfant C., Gifford R.W. Jr., Zuspan F. National High Blood Pressure On Education Program Working Group report on high blood pressure in pregnancy. consesus report. Am. J. Obstet. Gynecol. 163:1990;1689-1712.
8. Kitzmiller J.L., Benirschke K. Immunofluorescent study of placental bed vessels in pre-eclampsia. Am. J. Obstet. Gynecol. 115:1973;248-251.
9. Blumenfeld Z., Brenner B. Thrombophilia-associated pregnancy wastage. Fertil. Steril. 72:1999;765-774.
10. Lockwood C.J. Heritable coagulopathies in pregnancy. Obstet. Gynecol. Surv. 54:1999;754-765.
11. Bertina R.M., Koeleman B.P., Koster T., Rosendaal F.R., Dirven R.J., de Ronde H., van der Velden P.A., Reitsma P.H. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 369:1994;64-67.
12. Dekker G.A., de Vries J.I.P., Doelitzsch P.M., Huijgens P.C., von Blomberg B.M., Jakobs C., van Geijn H.P. Underlying disorders associated with severe early onset preeclampsia. Am. J. Obstet. Gynecol. 173(4):1995;1042-1048.
13. Dizon-Townson D.S., Nelson L.M., Easton K., Ward K. The factor V leiden mutation may predispose women to severe preeclampsia. Am. J. Obstet. Gynecol. 175:1996;902-905.
14. Rees D.C., Cox M., Clegg J.B. World distribution of factor V Leiden. Lancet. 346:1995;1133-1134.
15. Kodaira H., Ishida F., Shimodaira S., Takamiya O., Furihata K., Kitano K. Resistance to activated protein C and Arg 504 Gln factor V mutation are uncommon in eastern Asian populations. Acta Haematol. 98:1997;22-25.
16. Frosst P., Blomm H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.J.H., den Heijer M., Kluijtmans L.A.J., van den Heuvel L.P., Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10:1995;111-113.
17. Prasmusinto D., Skrablin S., Hofstaetter C., Fimmers R., van der Ven K. The methylenetetrahydrofolate reductase 677 C-T polymorphism and preeclampsia in two populations. Obstet. Gynecol. 99:2002;1085-1092.
18. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215.
19. Pijnenborg R., Anthony J., Davey D.A., Rees A., Tiltman A., Vercruysse L., van Assche A. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br. J. Obstet. Gynaecol. 98(7):1991;648-655.
20. Roberts J.M., Taylorr R.N., Friedman S.A., Goldfien A. New developments in preeclampsia. Fetal Med. Rev. 2:1990;125-141.
21. de Groot C.J.M., Taylor R.N. Preeclampsia: an update. Eur. J. Obstet. Gynecol. Reprod. Biol. 69:1996;59-60.
22. Weiner C.P., Kwaan H.C., Xu C., Paul M., Burneister L., Hauck W. Antithrombin III activity in women with hypertension during pregnancy. Obstet. Gynecol. 65:1985;301-306.
23. Grandone E., Margaglione M., Colaizze D., Cappucci G., Paladini D., Martinelli P., Montanaro S., Pavone G., Di Minno G. Factor V Leiden, C → T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb. Haemost. 77:1997;1052-1054.
24. Nagy B., Toth T., Rigo J. Jr., Karadi I., Romics L., Papp Z. Detection of factor V Leiden mutation in severe pre-eclamptic Hungarian women. Clin. Genet. 53:1998;478-481.
25. Murphy R.P., Donoghue C., Nallen R.J., D'Mello M., Regan C., Whitehead A.S., Fitzgerald D.J. Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy. Arterioscler. Thromb. Vasc. Biol. 20(1):2000;266-270.
26. Rigo J. Jr., Nagy B., Fintor L., Tanyi J., Beke A., Karadi I., Papp Z. Maternal and neonatal outcome of preeclamptic pregnancies: the potential roles of factor V Leiden mutation and 5,10-methylenetetrahydrofolate reductase. Hypertens. Pregnancy. 19(2):2000;163-172.
27. van Pampus M.G., Dekker G.A., Wolf H., Huijgens P.C., Koopman M.M., von Blomberg B.M., Buller H.R. High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia. Am. J. Obstet. Gynecol. 180:1999;1146-1150.
28. van Pampus M.G., Wolf H., Koopman M.M., van den Ende A., Buller H.R., Reitsma P.H. Prothrombin 20210 G: a mutation and factor V Leiden mutation in women with a history of severe preeclampsia and (H)ELLP syndrome. Hypertens. Pregnancy. 20(3):2001;291-298.
29. O'Shaughnessy K.M., Fu B., Ferraro F., Lewis I., Downing S., Morris N.H. Factor V Leiden and thermolabile methylenetetrahydrofolate reductase gene variants in an East Anglian preeclampsia cohort. Hypertension. 33:1999;1338-1341.
30. De Groot C.J., Bloemenkamp K.W., Duvekot E.J., Helmerhorst F.M., Bertina R.M., Van Der Meer F., De Ronde H., Oei S.G., Kanhai H.H., Rosendaal F.R. Preeclampsia and genetic risk factors for thrombosis: a case-control study. Am. J. Obstet. Gynecol. 181:1999;975-980.
31. Livingston J.C., Barton J.R., Park V., Haddad B., Phillips O., Sibai B.M. Maternal and fetal inherited thrombophilias are not related to the development of severe preeclampsia. Am. J. Obstet. Gynecol. 185(1):2001;153-157.
32. Kim Y.J., Williamson R.A., Murray J.C., Andrews J., Pietscher J.J., Peraud P.J., Merrill D.C. Genetic susceptibility to preeclampsia: roles of cytosineto-thymine substitution at nucleotide 677 of the gene for methylenetetrahydrofolate reductase, 68-base pair insertion at nucleotide 844 of the gene for cystathionine beta-synthase, and factor V Leiden mutation. Am. J. Obstet. Gynecol. 184(6):2001;1211-1217.
33. Currie L., Peek M., McNiven M., Prosser I., Mansour J., Ridgway J. Is there an increased maternal-infant prevalence of factor V Leiden in association with severe pre-eclampsia? BJOG. 109(2):2002;191-196.
34. Morrison E.R., Miedzybrodzka Z.H., Campbell D.M., Haites N.E., Wilson B.J., Watson M.S., Greaves M., Vickers M.A. Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review. Thromb. Haemost. 87(5):2002;779-785.
35. D'Elia A.V., Driul L., Giacomello R., Colaone R., Fabbro D., Di Leonardo C., Florio P., Petraglia F., Marchesoni D., Damante G. Frequency of factor V, prothrombin and methylenetetrahydrofolate reductase gene variants in preeclampsia. Gynecol. Obstet. Invest. 53(2):2002;84-87.
36. Kobashi G., Yamada H., Asano T., Nagano S., Hata A., Kishi R., Kondo K., Fujimoto S. The factor V Leiden mutation is not a common cause of pregnancy-induced hypertension in Japan. Semin. Thromb. Hemost. 25:1999;487-489.
37. Sohda S., Arinami T., Hamada H., Yamada N., Hamaguchi H., Kubo T. Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. J. Med. Genet. 34(6):1997;525-526.
38. Kupferminc M.J., Fait G., Many A., Gordon D., Eldor A., Lessing J.B. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N. Engl. J. Med. 340(1):1999;9-13.
39. Rath W., Heilmann L., Faridi A. Empfehlungen für diagnostik und therapie bei Bluthochdruck in der Schwangerschaft. Frauenarzt. 41:2000;139-142.